Compare BURL & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BURL | STE |
|---|---|---|
| Founded | 1972 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Department/Specialty Retail Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 20.9B |
| IPO Year | 2013 | 2018 |
| Metric | BURL | STE |
|---|---|---|
| Price | $327.01 | $208.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 5 |
| Target Price | ★ $355.29 | $275.20 |
| AVG Volume (30 Days) | ★ 1.1M | 770.1K |
| Earning Date | 05-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | 21.92 | ★ 27.90 |
| EPS | 1.79 | ★ 7.93 |
| Revenue | ★ $11,566,910,000.00 | $5,935,900,000.00 |
| Revenue This Year | $12.72 | $9.88 |
| Revenue Next Year | $8.47 | $6.32 |
| P/E Ratio | $181.24 | ★ $26.84 |
| Revenue Growth | ★ 8.76 | 8.73 |
| 52 Week Low | $224.00 | $195.14 |
| 52 Week High | $351.85 | $269.44 |
| Indicator | BURL | STE |
|---|---|---|
| Relative Strength Index (RSI) | 55.48 | 40.33 |
| Support Level | $286.91 | $195.14 |
| Resistance Level | $333.51 | $227.10 |
| Average True Range (ATR) | 13.77 | 4.82 |
| MACD | 1.65 | -0.17 |
| Stochastic Oscillator | 85.44 | 2.10 |
Burlington Stores Inc is an off-price retailer offering an extensive selection of in-season, fashion-focused merchandise, including women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts, and coats. The company sells a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. It sells products in categories such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby, and Outerwear.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.